This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Dovato
  • /
  • Safety and Efficacy of Dolutegravir/Lamivudine (DT...
Clinical trial

Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents

Read time: 1 mins
Last updated:8th Jul 2020
Status: Recruiting
Identifier: NCT03682848
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest